Posted: September 14, 2020

Letter of Intent due 30 days prior to application; Applications due November 12, 2020

This Funding Opportunity Announcement (FOA) is designed to support genomic programs managed by the Center for Cancer Genomics (CCG). The overall goal of all CCG programs is to help elucidate the mechanisms of cancer initiation and evolution, as well as resistance to therapy by means of genomic characterization of well-annotated, high quality tumor samples. These data could, in the future, be used to identify and accelerate the development of new diagnostic and prognostic markers, new targets for pharmaceutical interventions, and new cancer prevention and treatment strategies. It is not the intent of this FOA to fund follow-up translational and functional studies, but rather to enable the cancer research community to develop a new generation of studies that will leverage the genomic findings from NCI programs for the benefit of cancer patients. NCI project data, both ongoing and completed, will provide a unique reference resource on cancer-specific genomic aberrations for the cancer research community at large.

See full solicitation here

Office of Grants and Contracts

Address

107 Ag Administration Building
University Park, PA 16802